Logo Image
News
All NewsDosing & Delivery InnovationsPress ReleasesProduct Approvals and Launches
Watch
Expert ConversationsNews & AnalysisShows & Podcasts
Journals
All JournalsThe American Journal of Managed CarePopulation Health, Equity & OutcomesEvidence-Based OncologyAbout Supplements and Featured PublicationsSupplements and Featured Publications IssuesSubmit a Manuscript
Conferences
Conference CoverageConference ListingPost Conference Perspectives
More
Events
AJMC EventsEvents CalendarInstitute for Value-Based MedicinePatient-Centered Oncology CarePopulation Health RoundtablesWebinars
Resources
Interactive ToolsFormulary CentralClinical SpotlightMicrositesSponsored Content
CE
About AJMC
AJMC StaffAnniversarySeema Sonnad AwardStrategic Alliance Partners

Subscribe

  • News
  • Watch
  • Journals
  • Conferences
  • Events
  • Resources
  • CE
  • About AJMC
  • Subscribe
  • Biosimilars
  • Cardiorenalmetabolic
    • Cardiomyopathy
    • Cardiovascular
    • Chronic Kidney Disease
    • Diabetes
    • Heart Failure
    • Type 1 Diabetes
  • Dermatology
    • Alopecia
    • Atopic Dermatitis
    • Chronic Hand Eczema
    • Psoriasis
  • Gastroenterology
  • Hematology
    • ALL/AML
    • CLL/SLL
    • GVHD
    • Hemophilia
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
    • Non-Hodgkin Lymphoma
    • Rare Blood
  • Hepatology
    • Hepatitis
    • Liver
    • MASH
  • Immunology
    • Allergy
    • Autoimmune
    • Inflammation
    • Lupus
    • Myasthenia Gravis
    • Rheumatoid Arthritis
  • Infectious Disease
    • COVID-19
    • HIV
    • RSV
    • Vaccines
  • Mental Health
    • Major Depressive Disorder
    • Sleep
  • Neurology
    • Duchenne Muscular Dystrophy
    • Epilepsy
    • Multiple Sclerosis
    • Parkinson Disease
  • Obesity
  • Oncology
    • Breast Cancer
    • Cholangiocarcinoma
    • Colorectal Cancer
    • Immuno-Oncology
    • Liver Cancer
    • Non–Small Cell Lung Cancer
    • Ovarian Cancer
    • Prostate Cancer
    • Skin Cancer
    • Small Cell Lung Cancer
    • Soft Tissue Sarcoma
  • Ophthalmology
  • Pulmonology
    • COPD
    • Pulmonary Arterial Hypertension
  • Rare Disease
    • Spinal Muscular Atrophy
  • Respiratory
    • Asthma
    • Pulmonary Fibrosis
  • Rheumatology
  • Urology
    • Overactive Bladder
  • Women's Health
    • Endometriosis
  • Biosimilars
  • Bispecifics Network
  • Center on Health Equity & Access
  • Digital Health
  • Dosing & Delivery Innovations
  • Formulary
  • Gene Therapy
  • Guidelines
  • Health Care Administration
    • Employers
    • Medicare
    • Reimbursement
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Population Health
  • Product Approvals and Launches
  • Technology
  • Value-Based Care
Spotlight -
Free In-Person Regional Events Focused on Oncology and Population Health
Advertisement

John E. Schneider, PhD

Advertisement

Articles by John E. Schneider, PhD

Reimbursement for Genetic Variant Reinterpretation: Five Questions Payers Should Ask

ByDavid L. Veenstra, PharmD, PhD,John W. Rowe, MD,José A. Pagán, PhD,H. Shelton Brown, PhD,John E. Schneider, PhD,Avni Gupta, BDS, MPH,Sara M. Berger, MS, CGC,Wendy K. Chung, MD, PhD,Paul S. Appelbaum, MD
October 14th 2021

Periodic reinterpretation of genetic sequencing results presents a challenge for developing transparent and systematic coverage and reimbursement policies.

Effects of Health Savings Account Eligible Plans on Utilization and Expenditures

ByMary E. Charlton, PhD,Barcey T. Levy, PhD, MD,Robin R. High, MBA, MA,John E. Schneider, PhD,John M. Brooks, PhD
January 29th 2011

The health savings account-eligible design may decrease costs and utilization, but it also may decrease use of preventive services.

Advertisement

Latest Updated Articles

  • Reimbursement for Genetic Variant Reinterpretation: Five Questions Payers Should Ask
    Reimbursement for Genetic Variant Reinterpretation: Five Questions Payers Should Ask

    October 14th 2021

  • Effects of Health Savings Account Eligible Plans on Utilization and Expenditures
    Effects of Health Savings Account Eligible Plans on Utilization and Expenditures

    January 29th 2011



Advertisement
Advertisement

Trending on AJMC

1

Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD

2

Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD

3

Counseling Vitiligo Patients on Time to Repigmentation

4

Cross-Trial Vitiligo Data: What Payers Can and Can't Compare

5

5 August FDA Approvals Marked by Novelty, Pushback

Brand Logo
  • About
  • Contact
  • Editorial Boards
  • Advertise
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2026 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text